513 related articles for article (PubMed ID: 27260166)
1. Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation.
Rocha SM; Saraiva T; Cristóvão AC; Ferreira R; Santos T; Esteves M; Saraiva C; Je G; Cortes L; Valero J; Alves G; Klibanov A; Kim YS; Bernardino L
J Neuroinflammation; 2016 Jun; 13(1):137. PubMed ID: 27260166
[TBL] [Abstract][Full Text] [Related]
2. Ultrafine carbon particles promote rotenone-induced dopamine neuronal loss through activating microglial NADPH oxidase.
Wang Y; Liu D; Zhang H; Wang Y; Wei L; Liu Y; Liao J; Gao HM; Zhou H
Toxicol Appl Pharmacol; 2017 May; 322():51-59. PubMed ID: 28283350
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of fucoidan in 6-hydroxydopamine-lesioned rat model of Parkinson's disease: Role of NADPH oxidase-1.
Zhang FL; He Y; Zheng Y; Zhang WJ; Wang Q; Jia YJ; Song HL; An HT; Zhang HB; Qian YJ; Tong YL; Dong L; Wang XM
CNS Neurosci Ther; 2014 Dec; 20(12):1036-44. PubMed ID: 25399812
[TBL] [Abstract][Full Text] [Related]
4. Apocyanin, a Microglial NADPH Oxidase Inhibitor Prevents Dopaminergic Neuronal Degeneration in Lipopolysaccharide-Induced Parkinson's Disease Model.
Sharma N; Nehru B
Mol Neurobiol; 2016 Jul; 53(5):3326-3337. PubMed ID: 26081143
[TBL] [Abstract][Full Text] [Related]
5. Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase.
Chéret C; Gervais A; Lelli A; Colin C; Amar L; Ravassard P; Mallet J; Cumano A; Krause KH; Mallat M
J Neurosci; 2008 Nov; 28(46):12039-51. PubMed ID: 19005069
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-3 causes dopaminergic neuronal death through Nox1-regenerated oxidative stress.
Choi DH; Kim JH; Seo JH; Lee J; Choi WS; Kim YS
PLoS One; 2014; 9(12):e115954. PubMed ID: 25536219
[TBL] [Abstract][Full Text] [Related]
7. Transient receptor potential vanilloid subtype 1 contributes to mesencephalic dopaminergic neuronal survival by inhibiting microglia-originated oxidative stress.
Park ES; Kim SR; Jin BK
Brain Res Bull; 2012 Nov; 89(3-4):92-6. PubMed ID: 22796104
[TBL] [Abstract][Full Text] [Related]
8. Microglial cells are involved in the susceptibility of NADPH oxidase knockout mice to 6-hydroxy-dopamine-induced neurodegeneration.
Hernandes MS; Santos GD; Café-Mendes CC; Lima LS; Scavone C; Munhoz CD; Britto LR
PLoS One; 2013; 8(9):e75532. PubMed ID: 24086556
[TBL] [Abstract][Full Text] [Related]
9. Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase.
Jiang L; Wu X; Wang S; Chen SH; Zhou H; Wilson B; Jin CY; Lu RB; Xie K; Wang Q; Hong JS
J Neuroinflammation; 2016 May; 13(1):110. PubMed ID: 27184631
[TBL] [Abstract][Full Text] [Related]
10. Formyl-methionyl-leucyl-phenylalanine-induced dopaminergic neurotoxicity via microglial activation: a mediator between peripheral infection and neurodegeneration?
Gao X; Hu X; Qian L; Yang S; Zhang W; Zhang D; Wu X; Fraser A; Wilson B; Flood PM; Block M; Hong JS
Environ Health Perspect; 2008 May; 116(5):593-8. PubMed ID: 18470306
[TBL] [Abstract][Full Text] [Related]
11. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
[TBL] [Abstract][Full Text] [Related]
12. Sinomenine, a natural dextrorotatory morphinan analog, is anti-inflammatory and neuroprotective through inhibition of microglial NADPH oxidase.
Qian L; Xu Z; Zhang W; Wilson B; Hong JS; Flood PM
J Neuroinflammation; 2007 Sep; 4():23. PubMed ID: 17880684
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation.
Chung YC; Bok E; Huh SH; Park JY; Yoon SH; Kim SR; Kim YS; Maeng S; Park SH; Jin BK
J Immunol; 2011 Dec; 187(12):6508-17. PubMed ID: 22079984
[TBL] [Abstract][Full Text] [Related]
14. NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease.
Choi DH; Cristóvão AC; Guhathakurta S; Lee J; Joh TH; Beal MF; Kim YS
Antioxid Redox Signal; 2012 May; 16(10):1033-45. PubMed ID: 22098189
[TBL] [Abstract][Full Text] [Related]
15. NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration.
Qin L; Liu Y; Hong JS; Crews FT
Glia; 2013 Jun; 61(6):855-68. PubMed ID: 23536230
[TBL] [Abstract][Full Text] [Related]
16. DAP12 and CD11b contribute to the microglial-induced death of dopaminergic neurons in vitro but not in vivo in the MPTP mouse model of Parkinson's disease.
Kinugawa K; Monnet Y; Béchade C; Alvarez-Fischer D; Hirsch EC; Bessis A; Hunot S
J Neuroinflammation; 2013 Jul; 10():82. PubMed ID: 23844828
[TBL] [Abstract][Full Text] [Related]
17. NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson's disease.
Cheng L; Chen L; Wei X; Wang Y; Ren Z; Zeng S; Zhang X; Wen H; Gao C; Liu H
J Neuroinflammation; 2018 Aug; 15(1):243. PubMed ID: 30157869
[TBL] [Abstract][Full Text] [Related]
18. Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells.
Garrido-Gil P; Rodriguez-Pallares J; Dominguez-Meijide A; Guerra MJ; Labandeira-Garcia JL
Exp Neurol; 2013 Dec; 250():384-96. PubMed ID: 24184051
[TBL] [Abstract][Full Text] [Related]
19. Role and mechanism of microglial activation in iron-induced selective and progressive dopaminergic neurodegeneration.
Zhang W; Yan ZF; Gao JH; Sun L; Huang XY; Liu Z; Yu SY; Cao CJ; Zuo LJ; Chen ZJ; Hu Y; Wang F; Hong JS; Wang XM
Mol Neurobiol; 2014 Jun; 49(3):1153-65. PubMed ID: 24277523
[TBL] [Abstract][Full Text] [Related]
20. GPER activation is effective in protecting against inflammation-induced nigral dopaminergic loss and motor function impairment.
Mendes-Oliveira J; Lopes Campos F; Videira RA; Baltazar G
Brain Behav Immun; 2017 Aug; 64():296-307. PubMed ID: 28450223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
